Last reviewed · How we verify
NCT02121054
Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
trial in Cardiovascular Diseases in 1,527 participants. Completed in 29 October 2020.
29 October 2020
Quick facts
| Lead sponsor | Young-Hak Kim, MD, PhD |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,527 |
| Start date | 19 October 2013 |
| Primary completion | 29 October 2020 |
| Estimated completion | 29 October 2020 |
| Sites | 1 location across South Korea |
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Young-Hak Kim, MD, PhD
Who can join
20 and older, any sex, with Cardiovascular Diseases or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02121054
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Young-Hak Kim, MD, PhD trials
Trials by the same sponsor.
- NCT02814578 — Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbabl · NA · terminated
- NCT02649881 — Diagnosis of Macrophage Coronary Plaque by Optical Tomographic Imaging · completed
- NCT02175186 — Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coro · Phase 4 · completed
- NCT02208388 — Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial · NA · recruiting
- NCT01696006 — Perfusion CT Registry · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02121054 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Young-Hak Kim, MD, PhD
- Last refreshed: 20 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02121054.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing